Free Access
| Issue |
Med Sci (Paris)
Volume 41, Number 2, Février 2025
Nos jeunes pousses ont du talent !
|
|
|---|---|---|
| Page(s) | 198 - 200 | |
| Section | Partenariat médecine/sciences - Écoles doctorales - Masters | |
| DOI | https://doi.org/10.1051/medsci/2025020 | |
| Published online | 03 March 2025 | |
- Arnold M, Singh D, Laversanne M, et al. Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040. JAMA Dermatol 2022 ; 158 : 495. [CrossRef] [PubMed] [Google Scholar]
- Bhave P, Ahmed T, Lo SN, et al. Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. J Immunother Cancer 2022 ; 10 : e004668. [CrossRef] [PubMed] [Google Scholar]
- Wolchok JD, Chiarion-Sileni V, Gonzalez R, et al. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. JCO 2022 ; 40 : 127–137. [CrossRef] [PubMed] [Google Scholar]
- Jaiswal AR, Liu AJ, Pudakalakatti S, et al. Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype. Cancer Immunol Res 2020 ; 8 : 1365–1380. [CrossRef] [PubMed] [Google Scholar]
- Garland KM, Kwiatkowski AJ, Tossberg JT, et al. Nanoparticle Delivery of Immunostimulatory Alu RNA for Cancer Immunotherapy. Cancer Res Commun 2023 ; 3 : 1800–1809. [CrossRef] [PubMed] [Google Scholar]
- Mighell AJ, Markham AF, Robinson PA. Alu sequences. FEBS Letters 1997 ; 417 : 1–5. [CrossRef] [PubMed] [Google Scholar]
- Samuel CE. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses. J Biol Chem 2019 ; 294 : 1710–1720. [CrossRef] [PubMed] [Google Scholar]
- Tossberg JT, Heinrich RM, Farley VM, et al. Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds) RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses. J Immunol 2020 ; 205 : 2606–2617. [CrossRef] [PubMed] [Google Scholar]
- Cheon H, Wang Y, Wightman SM, et al. How cancer cells make and respond to interferon-I. Trends Cancer 2023 ; 9 : 83–92. [CrossRef] [PubMed] [Google Scholar]
- Overwijk WW, Restifo NP. B16 as a Mouse Model for Human Melanoma. CP Immunol 2000 ; 39. [Google Scholar]
- Carson CS, Becker KW, Garland KM, et al. A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA. J Control Release 2022 ; 345 : 354–370. [CrossRef] [PubMed] [Google Scholar]
- Jacobson ME, Becker KW, Palmer CR, et al. Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists. ACS Cent. Sci 2020 ; 6 : 2008–2022. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.